Fifth Third Bancorp
IMVT icon

Fifth Third Bancorp’s Immunovant IMVT Stock Holding History

Fifth Third Bancorp’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.92K Buy
+319
New +$8.26K ﹤0.01% 3755
2020
Q4 		– Sell
-5,587
Closed -$197K – 2400
2020
Q3 		$197K Hold
5,587
– – ﹤0.01% 878
2020
Q2 		$136K Buy
+5,587
New +$120K ﹤0.01% 995

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fifth Third Bancorp's IMVT Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Immunovant (IMVT) in Q1 2026: 319 shares worth $7.92K. The stake represents ﹤0.01% of the portfolio and ranks #3755 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in IMVT as recently as Q3 2020.

Fifth Third Bancorp first reported a position in IMVT in Q2 2020 and has held it in 3 quarters since. The position peaked at $197K in Q3 2020. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Fifth Third Bancorp held 319 shares of Immunovant worth $7.92K as of Q1 2026.
  • Immunovant was a new Fifth Third Bancorp position in Q1 2026.
  • Immunovant made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3755 holding.
  • Fifth Third Bancorp first reported a position in Immunovant in Q2 2020 and has held it in 3 quarters since.
  • Fifth Third Bancorp's Immunovant position peaked at $197K in Q3 2020.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.